Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Neurocrine Adds Epilepsy Assets From Xenon
Xenon will have freedom to focus on later-stage pipeline
Dec 02 2019
•
By
Joseph Haas
Neurocrine thinks XEN901 offers potential in multiple epilepsy indications
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Strategy
More from Business